DACLIZUMAB vs DALTEPARIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DACLIZUMAB vs DALTEPARIN: Safety Overview
| Metric | DACLIZUMAB | DALTEPARIN |
|---|---|---|
| Total FAERS Reports | 2,801 | 3,570 |
| Deaths Reported | 193 | 789 |
| Death Rate | 6.9% | 22.1% |
| Hospitalizations | 835 | 1,443 |
| Average Patient Age | 45.7 yrs | 67.7 yrs |
| % Female Patients | 81.5% | 39.7% |
| FDA Approval Date | N/A | Apr 4, 2002 |
| Manufacturer | N/A | Pfizer Laboratories Div Pfizer Inc |
| Route | N/A | SUBCUTANEOUS |
| Marketing Status | Prescription | Prescription |